AVNS
Price
$12.35
Change
-$0.03 (-0.24%)
Updated
Jul 3 closing price
Capitalization
919.92M
38 days until earnings call
RSLS
Price
$2.37
Change
-$0.05 (-2.07%)
Updated
Jul 3 closing price
Capitalization
4.33M
Interact to see
Advertisement

AVNS vs RSLS

Header iconAVNS vs RSLS Comparison
Open Charts AVNS vs RSLSBanner chart's image
Avanos Medical
Price$12.35
Change-$0.03 (-0.24%)
Volume$144.22K
Capitalization919.92M
ReShape Lifesciences
Price$2.37
Change-$0.05 (-2.07%)
Volume$76.82K
Capitalization4.33M
AVNS vs RSLS Comparison Chart in %
Loading...
AVNS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RSLS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AVNS vs. RSLS commentary
Jul 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AVNS is a Hold and RSLS is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 05, 2025
Stock price -- (AVNS: $12.35 vs. RSLS: $2.37)
Brand notoriety: AVNS and RSLS are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: AVNS: 32% vs. RSLS: 2%
Market capitalization -- AVNS: $919.92M vs. RSLS: $4.33M
AVNS [@Medical Specialties] is valued at $919.92M. RSLS’s [@Medical Specialties] market capitalization is $4.33M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.67B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AVNS’s FA Score shows that 0 FA rating(s) are green whileRSLS’s FA Score has 0 green FA rating(s).

  • AVNS’s FA Score: 0 green, 5 red.
  • RSLS’s FA Score: 0 green, 5 red.
According to our system of comparison, RSLS is a better buy in the long-term than AVNS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AVNS’s TA Score shows that 3 TA indicator(s) are bullish while RSLS’s TA Score has 4 bullish TA indicator(s).

  • AVNS’s TA Score: 3 bullish, 5 bearish.
  • RSLS’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, RSLS is a better buy in the short-term than AVNS.

Price Growth

AVNS (@Medical Specialties) experienced а +1.48% price change this week, while RSLS (@Medical Specialties) price change was -0.42% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +1.95%. For the same industry, the average monthly price growth was +1.48%, and the average quarterly price growth was -0.02%.

Reported Earning Dates

AVNS is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Medical Specialties (+1.95% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AVNS($920M) has a higher market cap than RSLS($4.33M). AVNS YTD gains are higher at: -22.425 vs. RSLS (-97.874). AVNS has higher annual earnings (EBITDA): 53.2M vs. RSLS (-36.72M). AVNS has more cash in the bank: 87.7M vs. RSLS (1.45M). RSLS has less debt than AVNS: RSLS (285K) vs AVNS (209M). AVNS has higher revenues than RSLS: AVNS (673M) vs RSLS (9.81M).
AVNSRSLSAVNS / RSLS
Capitalization920M4.33M21,272%
EBITDA53.2M-36.72M-145%
Gain YTD-22.425-97.87423%
P/E Ratio51.86N/A-
Revenue673M9.81M6,863%
Total Cash87.7M1.45M6,052%
Total Debt209M285K73,333%
FUNDAMENTALS RATINGS
AVNS vs RSLS: Fundamental Ratings
AVNS
RSLS
OUTLOOK RATING
1..100
2349
VALUATION
overvalued / fair valued / undervalued
1..100
89
Overvalued
42
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9798
PRICE GROWTH RATING
1..100
8198
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

RSLS's Valuation (42) in the Medical Specialties industry is somewhat better than the same rating for AVNS (89). This means that RSLS’s stock grew somewhat faster than AVNS’s over the last 12 months.

RSLS's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as AVNS (100). This means that RSLS’s stock grew similarly to AVNS’s over the last 12 months.

AVNS's SMR Rating (97) in the Medical Specialties industry is in the same range as RSLS (98). This means that AVNS’s stock grew similarly to RSLS’s over the last 12 months.

AVNS's Price Growth Rating (81) in the Medical Specialties industry is in the same range as RSLS (98). This means that AVNS’s stock grew similarly to RSLS’s over the last 12 months.

AVNS's P/E Growth Rating (100) in the Medical Specialties industry is in the same range as RSLS (100). This means that AVNS’s stock grew similarly to RSLS’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AVNSRSLS
RSI
ODDS (%)
N/A
Bullish Trend 3 days ago
81%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
67%
Bullish Trend 3 days ago
88%
Momentum
ODDS (%)
Bullish Trend 3 days ago
61%
Bearish Trend 3 days ago
90%
MACD
ODDS (%)
Bullish Trend 3 days ago
60%
Bullish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
61%
Bearish Trend 3 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
66%
Bearish Trend 3 days ago
90%
Advances
ODDS (%)
Bullish Trend 6 days ago
58%
N/A
Declines
ODDS (%)
Bearish Trend 3 days ago
71%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
67%
Bullish Trend 3 days ago
89%
Aroon
ODDS (%)
Bearish Trend 3 days ago
71%
Bearish Trend 3 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
AVNS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RSLS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RYDHX106.160.83
+0.79%
Rydex Dow Jones Industrial Average® H
AWSIX17.390.12
+0.69%
Invesco Global Core Equity R5
FSTLX34.070.21
+0.62%
Federated Hermes MDT Large Cap Value R6
SCAYX11.580.06
+0.52%
Invesco Income Advantage U.S. Fund Y
FAASX29.640.12
+0.41%
Fidelity Advisor Asset Manager 70% A

AVNS and

Correlation & Price change

A.I.dvisor indicates that over the last year, AVNS has been loosely correlated with STE. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if AVNS jumps, then STE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AVNS
1D Price
Change %
AVNS100%
-0.24%
STE - AVNS
44%
Loosely correlated
-0.29%
UTMD - AVNS
43%
Loosely correlated
+1.66%
TMCI - AVNS
42%
Loosely correlated
+1.48%
CNMD - AVNS
41%
Loosely correlated
+0.20%
RVTY - AVNS
41%
Loosely correlated
+0.41%
More

RSLS and

Correlation & Price change

A.I.dvisor indicates that over the last year, RSLS has been loosely correlated with BIAF. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if RSLS jumps, then BIAF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RSLS
1D Price
Change %
RSLS100%
-2.07%
BIAF - RSLS
44%
Loosely correlated
-6.07%
PFGTF - RSLS
29%
Poorly correlated
N/A
AVNS - RSLS
25%
Poorly correlated
-0.24%
SRDX - RSLS
24%
Poorly correlated
+3.41%
OSSUY - RSLS
23%
Poorly correlated
N/A
More